Literature DB >> 10223558

Colonic mucosal proliferation is related to serum deoxycholic acid levels.

T Ochsenkühn1, E Bayerdörffer, A Meining, M Schinkel, C Thiede, V Nüssler, M Sackmann, R Hatz, A Neubauer, G Paumgartner.   

Abstract

BACKGROUND: Hyperproliferation of the colorectal mucosa is regarded as an early step in colorectal carcinogenesis. Deoxycholic acid, a secondary bile acid, stimulates colorectal epithelial proliferation in animals and is considered a tumor promoter in human colorectal carcinogenesis. The aim of this study was to investigate the correlation between colorectal mucosal proliferation and the serum deoxycholic acid level.
METHODS: From each of 19 patients (10 men and 9 women) with (n = 3) or without (n = 16) colorectal adenoma, 18 biopsy specimens were obtained by colonoscopy, 3 from each of the 6 colonic segments. A crude nuclei fraction was prepared, and DNA was stained by propidium iodide to determine the proliferative index (the percentage of cells in the S and G2/M phases of the cell cycle) by flow cytometry. Serum levels of deoxycholic acid were determined by gas-liquid chromatography.
RESULTS: The colonic proliferation rates (median of the values obtained in all segments, 14.1%; range, 10.0-18.7%) and the fasting serum deoxycholic acid levels (median, 0.86 micromol/L; range, 0.28-1.58 micromol/L) showed a significant correlation (r = 0.51, P = 0.03). Serum lithocholic, cholic, chenodeoxycholic, and ursodeoxycholic acid levels were not correlated with the proliferation rates.
CONCLUSIONS: Levels of deoxycholic acid in serum are correlated with the rates of the colorectal mucosa. These results are consistent with the concept that deoxycholic acid promotes colorectal carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10223558

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  37 in total

Review 1.  Cholecystectomy and the risk of alimentary tract cancers: a systematic review.

Authors:  Maria Coats; Sami M Shimi
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

Review 2.  Cancer.

Authors:  Adda Grimberg
Journal:  Adv Exp Med Biol       Date:  2005       Impact factor: 2.622

Review 3.  Differential regulation of EGFR-MAPK signaling by deoxycholic acid (DCA) and ursodeoxycholic acid (UDCA) in colon cancer.

Authors:  Sara M Centuori; Jesse D Martinez
Journal:  Dig Dis Sci       Date:  2014-06-11       Impact factor: 3.199

4.  Is ileal pouch-anal anastomosis after Whipple procedure doable?

Authors:  C Benlice; E Gorgun
Journal:  Tech Coloproctol       Date:  2016-05-03       Impact factor: 3.781

5.  Risk modification of colorectal adenoma by CYP7A1 polymorphisms and the role of bile acid metabolism in carcinogenesis.

Authors:  Betsy C Wertheim; Jeffrey W Smith; Changming Fang; David S Alberts; Peter Lance; Patricia A Thompson
Journal:  Cancer Prev Res (Phila)       Date:  2011-11-04

Review 6.  The Role of the Gut Microbiome in Colorectal Cancer.

Authors:  Grace Y Chen
Journal:  Clin Colon Rectal Surg       Date:  2018-04-01

Review 7.  Acromegaly: re-thinking the cancer risk.

Authors:  Siobhan Loeper; Shereen Ezzat
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

Review 8.  Colorectal polyps in the elderly: what should be done?

Authors:  Kenneth Miller; Jerome D Waye
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

9.  Fecal primary bile acids and serum cholesterol are associated with colorectal adenomas.

Authors:  Séverine Meance; Marie-Christine Boutron-Ruault; Anne Myara; Marie-France Gerhardt; Philippe Marteau; Anne Lavergne; Claire Franchisseur; Christine Bouley
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

10.  Colonic interposition in a woman with attenuated familial adenomatosis polyposis: does the location of the colon affect polyp formation?

Authors:  Melanie D Beaton; Brian Taylor; David Driman; Peter Ainsworth; Paul C Adams
Journal:  Can J Gastroenterol       Date:  2008-07       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.